Join Weave at DPHARM 2025 – See How AI is Changing the Way We Build Regulatory Documents

We’re excited to share that Weave will be taking the stage at the 2025 DPHARM conference—a premier event spotlighting innovation in clinical development and R&D. DPHARM brings together top minds across pharma, biotech, and technology to challenge the status quo and accelerate smarter drug development.

Talk Details
Title: AI-Assisted Regulatory Writing: Findings from a Top 20 Pharma Case Study
Speaker: Lindsay Mateo, Chief Commercial Officer, Weave
Date: [Insert confirmed date]
Time: 1:55 – 2:05 PM Eastern Time
Location: The Westin Copley Place, Boston, MA
Event Website: dpharmconference.com

Session Overview
This session unveils final, unpublished findings from a groundbreaking collaboration between Weave and a Top 20 global pharmaceutical company. The study compares traditional regulatory writing with AI-assisted drafting using real-world data from previously submitted INDs—specifically Sections 2.6.2, 2.6.4, and 2.6.6, known for their complexity and criticality.

Key Takeaways:

• A side-by-side comparison of human-only vs. AI-augmented drafting
• A structured framework to evaluate speed and quality
• Actionable insights for applying AI in regulatory workflows—without compromising scientific integrity

Attendees will walk away with a pragmatic, evidence-based perspective on how AI tools can support—not replace—human expertise in regulatory science.

Visit the Weave Booth
Stop by our exhibit table to connect with the Weave team, including CCO Lindsay Mateo and Daniel Pointing, ADBD.
You’ll get a live demo of The Weave Platform, our AI-native solution that’s helping top pharma teams streamline content development and lifecycle management for regulatory submissions.

Whether you're curious about where AI fits into your regulatory ecosystem or ready to modernize outdated workflows, we’d love to hear from you.

Let’s weave together the future of regulatory writing—see you at DPHARM!